Russell Investments Group’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$49.1K Buy
2021
Q1
Sell
2020
Q4
$120K Sell
2020
Q3
$148K Sell
2020
Q2
$106K Buy
2020
Q1
$63K Buy
2018
Q1
Sell
2017
Q4
$16K Sell
2017
Q3
$102K Sell
2017
Q2
$112K Buy
2017
Q1
$149K Sell
2016
Q4
$402K Buy